Ironwood Pharmaceuti (IRWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 105,524 | 121,540 | 92,154 | 110,952 | 176,109 |
| Receivables | 58,108 | 72,015 | 129,122 | 124,546 | 118,990 |
| TOTAL | $178,180 | $208,174 | $233,288 | $253,610 | $317,599 |
| Non-Current Assets | |||||
| PPE Net | 5,068 | 5,288 | 5,585 | 5,630 | 5,876 |
| Intangibles | 3,273 | 3,478 | 3,682 | 3,889 | 4,096 |
| Other Non-Current Assets | 209,099 | 221,879 | 228,518 | 260,934 | 275,649 |
| TOTAL | $217,440 | $230,645 | $237,785 | $270,453 | $285,621 |
| Total Assets | $395,620 | $438,819 | $471,073 | $524,063 | $603,220 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 199,800 | 199,560 | N/A | 199,083 |
| Accounts payable and accrued liabilities | 3,227 | 6,222 | 7,830 | 4,698 | 3,505 |
| Accrued Expenses | 39,126 | 43,278 | 65,585 | 73,449 | 99,707 |
| Other current liabilities | N/A | N/A | N/A | 199,321 | N/A |
| TOTAL | $45,510 | $252,442 | $276,101 | $280,579 | $305,390 |
| Non-Current Liabilities | |||||
| Long Term Debt | 425,000 | 275,000 | 300,000 | 325,000 | 400,000 |
| Other Non-Current Liabilities | 246,837 | 241,895 | 241,925 | 245,534 | 271,898 |
| TOTAL | $671,837 | $516,895 | $541,267 | $569,163 | $644,607 |
| Total Liabilities | $717,347 | $769,337 | $817,368 | $849,742 | $949,997 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 159,739 | 158,957 | 156,529 | 156,129 | 156,029 |
| Common Shares | 160 | 159 | 156 | 156 | 156 |
| Retained earnings | -1,703,637 | -1,702,777 | -1,698,615 | -1,697,528 | -1,712,849 |
| Other shareholders' equity | -470 | -922 | -3,031 | -3,215 | -1,073 |
| TOTAL | $-321,727 | $-330,518 | $-346,295 | $-325,679 | $-346,777 |
| Total Liabilities And Equity | $395,620 | $438,819 | $471,073 | $524,063 | $603,220 |